Small Molecule
Total Trials
8
As Lead Sponsor
As Collaborator
0
Total Enrollment
4,688
NCT00157716
MEND-CABG (MC-1 to Eliminate Necrosis and Damage in Coronary Artery Bypass Graft Surgery)
Phase: Phase 2
Role: Lead Sponsor
Start: Apr 30, 2004
Completion: Oct 31, 2005
NCT00157729
MATCHED (MC-1 and ACE Therapeutic Combination for Hypertensive Diabetics)
Start: Aug 31, 2004
Completion: Jul 31, 2005
NCT00402506
A Safety and Efficacy Study to Confirm the Cardioprotective Effects of MC-1 in Patients Undergoing High-Risk CABG
Phase: Phase 3
Start: Nov 30, 2006
Completion: Sep 30, 2007
NCT00917293
Safety and Efficacy of Pyridoxal 5' -Phosphate in the Treatment of Tardive Dyskinesia
Start: May 31, 2009
Completion: Aug 31, 2014
NCT01522417
Shortened Aggrastat® Versus Integrilin in Percutaneous Coronary Intervention
Start: Apr 30, 2012
Completion: Mar 31, 2019
NCT01766154
Pharmacokinetic Evaluation of Tirofiban Using a Single High-Dose Bolus In Subjects With Varying Degrees of Renal Function
Phase: Phase 1
Start: Jan 31, 2013
Completion: Mar 31, 2013
NCT04706013
Oral Pyridoxal 5'-Phosphate for the Treatment of Patients With PNPO Deficiency
Start: Feb 16, 2024
Completion: Nov 30, 2026
Loading map...